Table 7: Frequency of Hospitalizations by Cohort in COMPANION*.
| Number of Hospitalizations |
CRT-D†, No. (%) (n = 595) |
OPT†, No. (%) (n = 308) |
|---|---|---|
| 1 | 199 (33.4) | 71 (23.1) |
| 2 | 160 (26.9) | 43 (14.0) |
| 3 | 96 (16.1) | 26 (8.4) |
| 4 | 56 (9.4) | 20 (6.5) |
| 5 | 37 (6.2) | 15 (4.9) |
| 6 | 19 (3.2) | 4 (1.3) |
| >6 | 23 (3.9) | 10 (3.2) |
†
CRT-D indicates cardiac resynchronization therapy with defibrillation; OPT, optimal pharmacological therapy.
*
From Food and Drug Administration. Clinical Review. COMPANION (Comparison of Medical Therapy, Pacing and Defibrillatin in Heart Failure). PMA P030005. June 14, 2004. www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4063b1_07_P010012.S026%20FDA%20clinical%20%20review%20-%20Final.doc (Accessed June 2005) (18)